Andrew Cheng Email
President and CEO . Akero Therapeutics
How to contact Andrew Cheng
Join and see Andrew's contact info for free!Current Roles
Employees:
85Revenue:
$5.4MAbout
Akero Therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. Akero's lead clinical program, AKR-001, is a long-acting Fc fusion modified FGF21 protein and potential best-in-class treatment for NASH. AKR-001 builds upon two decades of work on FGF21 biology. It is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.Akero Therapeutics Address
601 Gateway BoulevardSouth San Francisco, CA
United States